The effect on mucosal healing with Pentasa sachet 4g in mild to moderate active small bowel Crohn's disease, evaluated by video capsule endoscopy after 6 and 12 weeks treatment.
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2012
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 09 Mar 2012 Actual patient number 3 added as reported by ClinicalTrials.gov.
- 23 Sep 2009 New trial record.